VJHemOnc is committed to improving our service to you

Share this video  

VJHemOnc is committed to improving our service to you

COMy Virtual 2020 | Where is myeloma I-O moving?

Saad Usmani, MD, FACP, Levine Cancer Institute & Atrium Health, Charlotte, NC, talks on where he believes the myeloma immuno-oncology (I-O) space is moving. Specifically, Dr Usmani mentions bispecific antibodies, checkpoint inhibition, and CAR-T cell therapy. This interview was recorded via an online conference call with The Video Journal of Hematological Oncology (VJHemOnc).

Sign-up for our Newsletter!

Keep up to date with all the latest news with our monthly newsletter